Ovarian clear cell carcinoma—bad endometriosis or bad endometrium?
Open Access
- 19 July 2011
- journal article
- editorial
- Published by Wiley in The Journal of Pathology
- Vol. 225 (2) , 157-160
Abstract
It has become increasingly clear that the four main histological subtypes of epithelial ovarian cancer (EOC), high‐grade serous, endometrioid, clear cell and mucinous, are entities with different epidemiologies, clinical presentations, responses to treatment, and ultimate outcomes. In fact, for all intents and purposes, they can be considered different diseases, their only common denominator being that they frequently involve the ovary and pelvic organs. However, clinical practice has not caught up with these insights and the treatment of EOC is that of a single disease entity. In part, this is because we lack detailed knowledge of the molecular mechanisms driving the pathogenesis of each disease, which is vital in order to develop therapeutic approaches against common driver events. In the last few years, mutations in ARID1A and PIK3CA have been described in a substantial fraction of cases of ovarian clear cell carcinoma, yet the paper by Yamamoto et al in this issue of The Journal of Pathology reveals that PIK3CA mutations can be detected in precursor endometriosis tissues. These and other recent observations underscore the importance of investigating whether mutations in the eutopic endometrium actually predispose to endometriosis and eventually to malignancy. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- PIK3CA mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinomaThe Journal of Pathology, 2011
- Genome-wide association study identifies a common variant associated with risk of endometrial cancerNature Genetics, 2011
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell CancerClinical Cancer Research, 2011
- Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomasThe Journal of Pathology, 2011
- Activation of mutated K‐ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosisThe Journal of Pathology, 2011
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasNew England Journal of Medicine, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell CarcinomaThe American Journal of Pathology, 2009
- Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosisInternational Journal of Cancer, 2002
- Clinical characteristics of clear cell carcinoma of the ovaryCancer, 2000